---
title: "AZENCO6 LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f93bc8b3-da3d-52e4-be92-ca4421852567
json: https://whiteintel.dev/api/public/dossier/f93bc8b3-da3d-52e4-be92-ca4421852567
identifier: oo:GB-COH-15725014
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# AZENCO6 LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-15725014`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f93bc8b3-da3d-52e4-be92-ca4421852567  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f93bc8b3-da3d-52e4-be92-ca4421852567  

## Ownership & control

### Owners / controllers

- **ASTRAZENECA TREASURY LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff
- **Astrazeneca Ab** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/4295cff5-5002-4d35-953f-cc2e1cde9924
- **Astrazeneca Treasury Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/7f4279b9-5df2-4e84-9390-1359ded0a5a4

### UBO chain (walk to the ultimate owner)

A **9-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `15725014`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2024-05-16
- **Registered office:** 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, England
- **SIC:** 82990

### Officers

- BOWDEN, Matthew Shaun — director · British · appointed 2024-05-16
- TATTERSALL, Hannah Victoria — director · British · appointed 2025-05-01
- KEMP, Adrian Charles Noel — director · British · appointed 2024-05-16 · resigned 2025-05-01

### Beneficial owners (Persons with Significant Control)

- [Astrazeneca Treasury Limited](https://whiteintel.dev/entity/7f4279b9-5df2-4e84-9390-1359ded0a5a4) — 75–100% shares · corporate PSC · United Kingdom — since 2024-05-16
- [Astrazeneca Ab](https://whiteintel.dev/entity/4295cff5-5002-4d35-953f-cc2e1cde9924) — 75–100% shares · corporate PSC · Sweden — ceased 2024-05-16

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/15725014

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AZENCO6 LIMITED**. Human view: https://whiteintel.dev/entity/f93bc8b3-da3d-52e4-be92-ca4421852567 · Structured JSON: https://whiteintel.dev/api/public/dossier/f93bc8b3-da3d-52e4-be92-ca4421852567._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._